The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Prothrombin complex concentrate (human) (Brand name: Kcentra)
- Manufactured by
FDA-approved indication: Urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding.
National Library of Medicine Drug Information Portal